The University of Chicago has received a $75 million donation to support the construction of a new cancer pavilion at UChicago Medicine, the university announced Thursday.
The gift comes from the AbbVie Foundation, a nonprofit dedicated to addressing health inequities, and will help fund an $815 million, 575,000-square-foot freestanding cancer center that will combine research, clinical treatment, and patient care.
“We are deeply honored by this generous donation, as it strengthens our commitment to advancing the health and vitality of the community—a core priority of our South Side–based institution,” said University of Chicago president Paul Alivisatos. “This significant contribution speaks to the confidence that the AbbVie Foundation has in UChicago as a pioneering medical institution dedicated to pursuing globally meaningful solutions to yet-unsolved challenges.”
The building, which will be called the AbbVie Foundation Cancer Pavilion, is set to open in 2027. It “will unify more than 200 leading cancer experts, who are now spread out across our campus, allowing us to collaborate very closely with one another to create something bigger than what we could achieve alone,” said Dr. Kunle Odunsi, director of the UChicago Medicine Comprehensive Cancer Center.